BPC-157 (Body Protection Compound-157) is a synthetic pentadecapeptide derived from a protein found in gastric juice, studied widely across tissue repair and recovery research.
| Purity | ≥99% (LC-MS verified) |
| Form | Lyophilized powder, preservative free |
| Storage | Cool and dry; refrigerate after reconstitution |
| Batch | COA available on request |
BPC-157 (Body Protection Compound-157) is a synthetic pentadecapeptide derived from a protein found in gastric juice, studied widely across tissue repair and recovery research.
BPC-157 (Body Protection Compound-157) is a synthetic peptide corresponding to a short section of a protein originally isolated from human gastric juice. It is unusually stable in solution compared with peptides of similar size — a property that made it a frequent subject of gastrointestinal and soft-tissue research models. It is catalogued under CAS 137525-51-0.
Supplied as lyophilized powder, sealed under vacuum and preservative free. Every lot is assayed by an independent laboratory using HPLC and LC-MS before release, and the certificate of analysis is tied to the lot number printed on the vial — not a generic sample from an earlier batch.
Supplied for laboratory research use only. Not for human consumption.
A recurring finding across the published literature is upregulation of vascular endothelial growth factor receptor 2 (VEGFR2) and its associated downstream pathways. Researchers have connected this to the formation of new microvasculature in injured-tissue models.
Multiple studies describe BPC-157 modulating nitric oxide synthase activity. Investigators have examined its effect on vascular tone in both directions — counteracting the effects of NO inhibitors and NO donors within the same model.
In vitro work has examined outgrowth and migration of tendon fibroblasts, together with upregulation of growth hormone receptor expression in those cells. This is one of the mechanisms proposed for the soft-tissue findings reported in animal studies.
Given its origin as a fragment of a gastric protein, a substantial share of the literature concerns intestinal epithelial integrity and the peptide's stability under gastric conditions.
This body of work is overwhelmingly preclinical and largely conducted in rodent models. BPC-157 has not completed human clinical trials and is not an approved drug in the United States.
Concentration is set by the volume of diluent added. For a 10mg vial, 2mL of bacteriostatic water yields 5mg/mL. Calculate the working concentration your protocol requires rather than following a generic figure.
| State | Temperature | Practical shelf life |
|---|---|---|
| Lyophilized, sealed | −20 °C | 24+ months |
| Lyophilized, sealed | 2–8 °C | ~12 months |
| Lyophilized, sealed | Room temperature | Weeks — transit only |
| Reconstituted, bacteriostatic water | 2–8 °C | ~3–4 weeks |
| Reconstituted, sterile water | 2–8 °C | Same session |
Lyophilized peptide is stable enough to survive shipping at ambient temperature, which is why cold-chain courier service is not required for transit. Long-term storage is a different matter — material intended to be held for months belongs in a freezer.
Protect from light, and avoid repeated freeze-thaw cycles. Each cycle causes measurable degradation, so dividing a reconstituted stock into single-use aliquots before freezing is preferable to thawing and refreezing one vial repeatedly.
Every lot is tested by an independent laboratory using two orthogonal methods. HPLC (high-performance liquid chromatography) establishes purity as a percentage of total peptide content, separating the target compound from truncated sequences and synthesis by-products. LC-MS (liquid chromatography–mass spectrometry) confirms molecular identity by mass.
Both matter. Purity alone is insufficient — a 99% pure sample of the wrong compound is still the wrong compound. Together the two tests establish identity and quality, which is why BPC-157 is released only after both pass.
The certificate of analysis references the lot number printed on your vial label. Request the COA for your lot at [email protected].
Peer-reviewed studies indexed in PubMed. Each links to the abstract and, where a free copy exists, to the full text. We link primary sources rather than summarising them second-hand.
Compounds studied alongside this one, or acting through related pathways.
Join the Peps Depot mailing list for high-demand restock alerts, subscriber-only offers, release updates and priority access — plus The Friday Brief, our weekly peptide research newsletter covering what actually moved that week. New compounds, new trial data, regulatory shifts.